Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ CD105 Monoclonal Antibody (209701)

Rat Monoclonal Antibody

Supplier:  Invitrogen™ MA523894

Catalog No. PIMA523894


Only null left
Add to Cart

Description

Description

In Western blots, this antibody shows 100% cross-reactivity with recombinant human Endoglin. Reconstitute at 0.5 mg/mL in sterile PBS.

CD105 or Endoglin is a Type I transmembrane protein, which is highly expressed on human vascular endothelial cells. It exists on an O- and N-glycosylated homodimer. Up regulation of endoglin expression has been demonstrated in tumor vasculature and proliferating cells, suggesting that it is a proliferation associated endothelial marker. CD105 binds to TGF beta 1 and 3 with high affinity but not to TGF beta 2.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD105
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
Q63961
ENG
Mouse myeloma cell line NS0-derived recombinant mouse Endoglin Glu21-Gly581 (predicted).
100 μg
Primary
Mouse
Antibody
IgG2a
Flow Cytometry, Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry
209701
Unconjugated
ENG
AI528660; AI662476; CD105; CD105 antigen; cell surface MJ7/18 antigen; Edg; END; Endo; Endoglin; endoglin (Osler-Rendu-Weber syndrome 1); Eng; HHT1; ORW; ORW1; S-endoglin; transmembrane glycoprotein
Rat
Protein A/G
RUO
13805
-20°C, Avoid Freeze/Thaw Cycles
Lyophilized
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.